Clinical Trial Update: Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating radiotherapy with immunotherapy for systemic effects in multiple myeloma; the study was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2021-08-05